Rubella IgG Avidity

The rubella IgG avidity test measures the binding strength of IgG antibodies to rubella virus. It helps distinguish recent primary infection (low avidity) from past infection or vaccination (high avidity). Used especially in pregnancy when rubella IgM is positive, it estimates infection timing and fetal risk. Low avidity suggests infection within weeks–months; high avidity indicates older immunity.

IgG avidity is the overall strength with which a person's polyclonal IgG antibodies bind a specific antigen. It increases over weeks as the immune response matures; low avidity suggests recent or primary infection, while high avidity indicates past or remote infection. Clinical avidity tests (often using chaotropic agents) help determine timing of infection, useful for infections such as toxoplasmosis or rubella.

Cost varies by country and laboratory: in India private labs commonly charge about ₹600–3,000; in the United States private lab fees typically range from roughly $50–300; in the United Kingdom testing is usually covered by the NHS when clinically indicated, while private testing may cost about £30–150. Confirm the exact price with your local laboratory or clinic before testing.

No—rubella IgG positivity during pregnancy generally indicates immunity from past infection or vaccination and is reassuring for fetal protection. Concern arises only if IgM is positive (or there’s recent seroconversion), which suggests recent infection and carries risk of congenital rubella, especially in early pregnancy. Discuss your results with your clinician; they may order IgM, IgG avidity, or fetal assessment if infection is suspected.

An isolated rubella IgG positive result usually means past vaccination or infection and indicates immunity; it’s reassuring and generally not worrisome. No treatment is needed. If you’re pregnant or planning pregnancy, confirm there’s no recent infection (IgM negative and/or high IgG avidity) with your clinician. If you have symptoms or unclear results, ask your healthcare provider for follow-up testing and advice.

A protective rubella IgG level in pregnancy is generally considered ≥10 IU/mL. Levels below 10 IU/mL indicate non‑immunity and potential susceptibility; some laboratories report an equivocal range (about 5–15 IU/mL) and may retest or use avidity testing. Non‑immune women are usually advised to receive MMR vaccination after delivery and to avoid pregnancy for one month afterward.